Start-up to develop new treatment for heart failure
Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company Mirabilis Therapeutics BV that was founded in 2015.
Mirabilis Therapeutics BV is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases.
For more information on Mirabilis Therapeutics BV, please visit: www.mirabilis-therapeutics.com
Also read
-
Céline Nicole strengthens collaboration between Maastricht University and HAS green academy in high-tech horticulture
UM and HAS collaboration takes shape: Céline Nicole bridges fundamental and applied research in high-tech horticulture.
-
ETpathfinder Smart Skills Lab shares Einstein Telescope knowledge with businesses
Research into the Einstein Telescope is generating valuable technological expertise. The new ETpathfinder Smart Skills Lab at Maastricht University aims to spread this new knowledge to small and medium-sized enterprises.
-
MaGIC summer school: physics teachers dive deep into gravitational waves
Last week saw the very first edition of the MaGIC Summer School take place in Maastricht. The event brought together secondary school physics teachers from around the world to learn more about gravitational waves and the Einstein Telescope.
